Drug-drug interaction with two different route of admi­nistration [Design Issues]

posted by Mr.Rao – India, 2022-07-27 10:31 (1078 d 22:34 ago) – Posting: # 23182
Views: 3,812

Dear All,

from below reference link they are concluded there is no clinically relevant drug–drug interaction between CHF 5993 and result of cimetidine co-administration, with total exposure increased by 16 %, and peak concentration by 26 %.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340825/


I need to know how they concluded.

Looking forward to hear in details.


Thansk,


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Why didn’t you ignore Ohlbe’s note? [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,684 registered users;
58 visitors (0 registered, 58 guests [including 28 identified bots]).
Forum time: 09:06 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5